MTOR and breast cancer: Mele et al. observed that G6PD blockade in breast cancer cells caused a congruous increase of autophagosomes formation independently from the mammalian target of rapamycin (mTOR) status, synergistically augmenting the lapatinib-induced cytotoxic effect on cancer cells [11].